Viewing Study NCT05909618


Ignite Creation Date: 2025-12-25 @ 4:36 AM
Ignite Modification Date: 2025-12-26 @ 3:38 AM
Study NCT ID: NCT05909618
Status: RECRUITING
Last Update Posted: 2025-07-22
First Post: 2023-05-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Sponsor: Sheba Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module